← Leaderboards
Patrick J Mc Grath
New York State Psychiatric Institute
$6,630,000
Attributed
$12,591,555
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2009–15$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$12,591,555 · 5
By mechanism
U01$8,942,332 · 1
R01$2,045,967 · 1
RC1$951,326 · 1
R10$651,653 · 1
M01$277 · 1
Top collaborators
- Ramin V Parsey10 shared
- Myrna M Weissman10 shared
Most similar at New York State Psychiatric Institute
Same institution · by research overlap
- Myrna M Weissman$29,661,636
- Mark D Underwood$5,647,567
- Donald F Klein$535,387
- Victoria Arango$11,157,004
Others in their field
Top investigators on “Treatment Outcome”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Judith S. Currier · University Of California Los Angeles$241,389,305
- James Dennis Neaton · Northwestern University$213,587,039
- Gregory H Reaman · National Childhood Cancer Foundation$207,581,079
- Constance Ann Benson · University Of California, San Diego$181,535,584
Research focus
Treatment OutcomeDisease RemissionMajor Depressive DisorderPharmaceutical PreparationsBrainResponseAdverse EventMental DepressionEtiologyClinical ManagementEscitalopramAntidepressive AgentsClinical AssessmentsBiosignatureExecutive FunctionElectroencephalographyBinding (Molecular Function)Data SetEmotionsBiocompatible MaterialsBupropionBiomarkerBaseChronic
Grant awards (19)
Biosignatures of Treatment Remission in Major Depression$457,863
U01 · FY2015 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$1,792,950
U01 · FY2013 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$141,638
U01 · FY2013 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$1,778,562
U01 · FY2012 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$548,996
U01 · FY2012 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$41,673
U01 · FY2012 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$29,926
U01 · FY2012 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$1,807,205
U01 · FY2011 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$614,421
U01 · FY2011 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$1,729,098
U01 · FY2010 · MH
Developing a PET biomarker to predict response in treatment-resistant depression$480,435
RC1 · FY2010 · MH · contact PI
Developing a PET biomarker to predict response in treatment-resistant depression$470,891
RC1 · FY2009 · MH · contact PI
ALCOHOL USE DISORDER IN PATIENTS TREATED FOR DEPRESSION$454,039
R01 · FY2004 · AA
Continuation PET$277
M01 · FY2004 · RR
ALCOHOL USE DISORDER IN PATIENTS TREATED FOR DEPRESSION$457,123
R01 · FY2003 · AA
ALCOHOL USE DISORDER IN PATIENTS TREATED FOR DEPRESSION$564,711
R01 · FY2002 · AA
ALCOHOL USE DISORDER IN PATIENTS TREATED FOR DEPRESSION$570,094
R01 · FY2001 · AA
PREDICTION OF OUTCOME DURING FLUOXETINE$251,135
R10 · FY2001 · MH
PREDICTION OF OUTCOME DURING FLUOXETINE CONTINUATION$400,518
R10 · FY2000 · MH